MedPath

VIOXX SUSPENSION 12.5MG/5ML

VIOXX SUSPENSION 12.5MG/5ML

Discontinued
DIN Number

02241109

Drug Class

Human

Market Date

May 8, 2000

Company
HC

merck frosst canada & cie, merck frosst canada & co.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02241109
AIG Number0138801003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M01AH02 ROFECOXIB
Product Specifications
Dosage FormSuspension
Route of AdministrationOral
AHFS Classification28:08.04.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

ROFECOXIBActive
Strength: 12.5 MG / 5 ML
Monograph: ROFECOXIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.